These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21167610)

  • 21. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M; Welte S; Mader O; Duchardt F; Fischer R; Hufnagel H; Scheurich P; Brock R
    J Cell Sci; 2005 Aug; 118(Pt 15):3339-51. PubMed ID: 16079278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug delivery of oligonucleotides by peptides.
    Lochmann D; Jauk E; Zimmer A
    Eur J Pharm Biopharm; 2004 Sep; 58(2):237-51. PubMed ID: 15296952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
    Tréhin R; Merkle HP
    Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-penetrating peptides as delivery vehicles for biology and medicine.
    Stewart KM; Horton KL; Kelley SO
    Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides.
    Jones AT
    Int J Pharm; 2008 Apr; 354(1-2):34-8. PubMed ID: 18068916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-penetrating peptides in drug development: enabling intracellular targets.
    Chen L; Harrison SD
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):821-5. PubMed ID: 17635156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
    Juliano RL
    Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
    Meade BR; Dowdy SF
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of cell-penetrating peptides for drug delivery.
    Temsamani J; Vidal P
    Drug Discov Today; 2004 Dec; 9(23):1012-9. PubMed ID: 15574317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey on "Trojan Horse" peptides: opportunities, issues and controlled entry to "Troy".
    Shi NQ; Qi XR; Xiang B; Zhang Y
    J Control Release; 2014 Nov; 194():53-70. PubMed ID: 25151981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.
    Juliano RL; Alam R; Dixit V; Kang HM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):324-35. PubMed ID: 20049800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape.
    Endoh T; Ohtsuki T
    Adv Drug Deliv Rev; 2009 Jul; 61(9):704-9. PubMed ID: 19383521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
    Mäe M; Langel U
    Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of cell-penetrating peptides.
    Vasconcelos L; Pärn K; Langel U
    Ther Deliv; 2013 May; 4(5):573-91. PubMed ID: 23647276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
    Ziegler A
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of cell penetrating peptides (CPPs).
    Kerkis A; Hayashi MA; Yamane T; Kerkis I
    IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics.
    Lukanowska M; Howl J; Jones S
    Biotechnol J; 2013 Aug; 8(8):918-30. PubMed ID: 23843291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
    Andaloussi SE; Lehto T; Lundin P; Langel U
    Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.